Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.656 EUR | +0.61% | -3.26% | +25.07% |
30/05 | Dexin China Gets Validation Order in Winding-up Case; Shares Up 12% | MT |
28/05 | Five Major Lenders Contribute to China's 344 Billion Yuan Integrated Circuit Fund | MT |
Strengths
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company appears to be poorly valued given its net asset value.
- The company is one of the best yield companies with high dividend expectations.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company's earnings growth outlook lacks momentum and is a weakness.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Sector: Banks
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+25.07% | 18TCr | - | ||
+19.12% | 58TCr | C+ | ||
+18.87% | 31TCr | C+ | ||
+15.71% | 25TCr | C+ | ||
+21.74% | 21TCr | C | ||
+24.16% | 17TCr | B- | ||
+9.58% | 16TCr | C+ | ||
+11.18% | 15TCr | B- | ||
-10.40% | 14TCr | B- | ||
+6.92% | 13TCr | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 939 Stock
- C6T Stock
- Ratings China Construction Bank Corporation